Trial Profile
An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2011
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 21 Nov 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 21 Nov 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 21 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.